A61P 1/08

Technology



back to "A61P 1/08" profile

More Results

Showing 1 to 20 of 27 results

Patent/Pub #TitleFiling DateIssue/Publication DatePatent Owner
9913910 Methods of treating nausea utilizing semi-solid delivery vehicle compositions comprising granisetronSep 19, 16Mar 13, 18HERON THERAPEUTICS, INC.
9675588 Ondansetron extended release solid dosage forms for treating either nausea, vomiting or diarrhea symptomsMar 11, 15Jun 13, 17REDHILL BIOPHARMA LTD.
9439920 Composition for the management of nausea and vomitingOct 03, 14Sep 13, 16DUCHESNAY INC.
9265724 Oral dosage form of tetrahydrocannabinol and a method of avoiding and/or suppressing hepatic first pass metabolism via targeted chylomicron/lipoprotein deliverySep 07, 10Feb 23, 16Not available
9227958 Amorphous and crystalline forms of aprepitant and processes for the preparation thereofFeb 02, 07Jan 05, 16GLENMARK PHARMACEUTICALS LIMITED
9066886 Transdermal drug delivery system containing granisetronAug 22, 08Jun 30, 15TAHO PHARMACEUTICALS LTD.
9066887 Transdermal therapeutic system having urea componentsDec 09, 08Jun 30, 15LTS LOHMANN THERAPIE-SYSTEME AG
9051273 Phosphodiesterase 4 inhibitor capable of avoiding vomitingAug 25, 12Jun 09, 15GUANGZHOU LANSSON PHARMACEUTICAL CO., LTD.
8901111 Aryl-substituted heterocyclic urea modulators of fatty acid amide hydrolaseJun 04, 10Dec 02, 14JANSSEN PHARMACEUTICA NV
8795634 Absorption of therapeutic agents across mucosal membranes or the skinSep 14, 09Aug 05, 14CRITICAL PHARMACEUTICALS LIMITED
8653063 N-substituted saturated heterocyclic sulfone compounds with CB2 receptor agonistic activityJan 22, 10Feb 18, 14ASKAT INC.
8623826 Compositions and methods for treating centrally mediated nausea and vomitingMar 31, 11Jan 07, 14HELSINN HEALTHCARE SA
8372883 Methods of using cycloalkylmethylaminesJul 05, 11Feb 12, 13Reviva Pharmaceuticals, Inc.
8304426 Polymorphic form of Granisetron base, methods for obtaining it and formulation containing itDec 20, 07Nov 06, 12INKE, S.A.
8278301 2-alkylbenzoxazole carboxamides as 5HT3 modulatorsMay 15, 09Oct 02, 12ALBANY MOLECULAR RESEARCH, INC., AMRI BOTHELL RESEARCH CENTER, INC., AMRI BURLINGTON, INC., AMRI RENESSELAER, INC.,
8252305 Methods of treating emesis utilizing semi-solid delivery pharmaceutical compositions comprising granisetronOct 24, 11Aug 28, 12HERON THERAPEUTICS, INC., A.P. Pharma,
8252306 Process for preparing a semi-solid delivery vehicle comprising granisetronOct 24, 11Aug 28, 12HERON THERAPEUTICS, INC.
8114866 Derivatives of 1-piperazine- and 1-homopiperazine-carboxylates, preparation method thereof and use of same as inhibitors of the FAAH enzymeFeb 08, 10Feb 14, 12SANOFI
8039460 CGRP receptor antagonistsOct 12, 05Oct 18, 11MERCK SHARP & DOHME CORP.
8026212 Methods of preparing pharmaceutical compositions comprising GPR119 agonists having the effect of glucose-dependent insulinotropic peptide secretatgoguesFeb 04, 10Sep 27, 11ARENA PHARMACEUTICALS, INC.

Showing 1 to 20 of 27 results